Context

Sponsor bias

• James R (1764) A dissertation on fevers and inflammatory distempers. 6th edn.
• Sollmann T (1917) The crucial test of therapeutic evidence.
• Hemminki E (1980) Study of information submitted by drug companies to licensing authorities.
• Davidson RA (1986) Source of funding and outcome of clinical trials.
• Gøtzsche PC (1987) Reference bias in reports of drug trials.
• Blumenthal D, Gluck M, Louis KS, Stoto MA, Wise D. (1996) Academic-industry relationships in the life sciences - an industry survey.
• Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.
• Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
• Yank V, Rennie D, Bero LA (2007) Financial ties and concordance between results: retrospective cohort study.
• Djulbegovic B, Kumar A, Soares HP, Hozo I, Bepler G, Clarke M, Bennett CL (2008) Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the national cancer institute-sponsored cooperative oncology groups, 1955 to 2006.
• Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (2008) Selective publication of antidepressant trials and Its influence on apparent efficacy.
• Rising K, Bacchetti P, Bero L (2008) Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.